Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC

Clinical trial NCT04905550 · UNKNOWN

Trial details

NCT number: NCT04905550
Sponsor: Chongqing University Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer (NSCLC)

Start date: 2021-03-01
Primary completion: 2024-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.